Want to see HK:9686 full AI Analyst Report?
NEUSOFT XIKANG HOLDINGS INC. (9686) AI Stock Analysis
NEUSOFT XIKANG HOLDINGS INC.
(HKEX:9686)
The overall score reflects an early-stage turnaround characterized by improving cash flows, narrowing losses, and a move to positive equity but still weak, unsustainable profitability and high leverage. Strong technical momentum and low beta support the score yet are tempered by overbought short-term readings, while the negative P/E and lack of dividend keep valuation unattractive.
NEUSOFT XIKANG HOLDINGS INC. (9686) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 820.83M
- Dividend Yield
- ―
- Average Volume (3M)
- 1.37M
- Price to Earnings (P/E)
- -45.4
- Beta (1Y)
- 0.09
- Revenue Growth
- -3.77%
- EPS Growth
- 73.89%
- Country
- Hong Kong
- Employees
- 725
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
NEUSOFT XIKANG HOLDINGS INC. Business Overview & Revenue Model
Company Description
Xikang Cloud Hospital Holdings Inc. specializes in constructing customized digital healthcare platforms designed for urban settings. Its business operations are structured into four main categories: Cloud Hospital Platform Services, Internet Medical...
How the Company Makes Money
Detailed, reliable information on NEUSOFT XIKANG HOLDINGS INC. (9686) revenue model, key revenue streams, and significant partnerships is not available in the provided context; null
NEUSOFT XIKANG HOLDINGS INC. Financial Statement Overview
Summary
Financials show a clear turnaround with strong revenue growth, sharply reduced losses, positive equity, and improving cash generation, but profitability is still unsustainable, leverage remains high, and operating cash flow coverage of obligations is limited.
Income Statement
54NeutralBalance Sheet
41NeutralCash Flow
61Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 468.40M | 464.14M | 501.50M | 537.72M | 687.41M | 614.30M |
| Gross Profit | 130.61M | 126.96M | 147.50M | 164.61M | 168.45M | 170.23M |
| EBITDA | 10.08M | -1.36M | -31.96M | -75.65M | -161.41M | -214.71M |
| Net Income | -17.47M | -38.93M | -83.05M | -154.65M | -241.97M | -296.54M |
Balance Sheet | ||||||
| Total Assets | 1.02B | 1.14B | 1.26B | 1.40B | 934.45M | 946.85M |
| Cash, Cash Equivalents and Short-Term Investments | 662.49M | 760.09M | 797.70M | 822.67M | 365.90M | 364.91M |
| Total Debt | 491.53M | 518.78M | 574.47M | 603.44M | 573.44M | 456.28M |
| Total Liabilities | 753.04M | 827.90M | 892.31M | 964.28M | 1.38B | 1.21B |
| Stockholders Equity | 270.67M | 313.54M | 363.31M | 428.14M | -451.98M | -274.55M |
Cash Flow | ||||||
| Free Cash Flow | 38.55M | 14.93M | 8.13M | -24.42M | -81.17M | -101.77M |
| Operating Cash Flow | 40.86M | 20.26M | 21.56M | -20.16M | -73.83M | -83.38M |
| Investing Cash Flow | -10.78M | -153.83M | 110.45M | -146.60M | -8.45M | -5.47M |
| Financing Cash Flow | -52.35M | -67.22M | -56.56M | 504.77M | 64.62M | 64.90M |
NEUSOFT XIKANG HOLDINGS INC. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:9686, the sentiment is Positive. The current price of 0.97 is below the 20-day moving average (MA) of 0.98, above the 50-day MA of 0.96, and above the 200-day MA of 0.92, indicating a bullish trend. The MACD of 0.00 indicates Positive momentum. The RSI at 55.92 is Neutral, neither overbought nor oversold. The STOCH value of 96.18 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:9686.
NEUSOFT XIKANG HOLDINGS INC. Peers Comparison
Overall Rating
- HK:968655Neutral
HK:225152Neutral
HK:072242Neutral
HK:213842Neutral
HK:388641Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:9686 | 55Neutral | HKD 820.84M | -45.36 | -5.98% | ― | -3.77% | 73.89% |
| HK:2251 | 52Neutral | HKD 904.97M | -11.11 | -5.98% | ― | 10.67% | 57.27% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:0722 | 42Neutral | HKD 292.35M | -3.79 | -10.76% | 9.04% | -1.37% | -334.69% |
| HK:2138 | 42Neutral | HKD 645.94M | -1.61 | -25.36% | ― | -8.94% | -140.82% |
| HK:3886 | 41Neutral | HKD 1.10B | 78.09 | 0.48% | 1.10% | -3.26% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:9686 | NEUSOFT XIKANG HOLDINGS INC. | 0.97 | 0.03 | 2.63% | |
| HK:2138 | EC Healthcare | 0.55 | -0.10 | -16.15% | |
| HK:2251 | Beijing Airdoc Technology Co. Ltd. Class H | 9.18 | -3.79 | -29.22% | |
| HK:2279 | Yonghe Medical Group Co., Ltd. | 2.10 | 0.20 | 10.55% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.16 | -0.11 | -40.07% | |
| HK:0722 | UMP Healthcare Holdings Limited | 0.36 | -0.07 | -16.67% |
NEUSOFT XIKANG HOLDINGS INC. Corporate Events
Xikang Cloud Hospital Narrows Loss as Policy Tailwinds Support AI-Enabled Healthcare Expansion
Xikang Cloud Hospital Holdings reported interim revenue of RMB182.9 million for the six months ended June 30, 2026, a 2.4% year-on-year increase, with gross margin improving to 23.5% and net loss narrowing by 45.1% to RMB27.4 million. The improvement...
Xikang Cloud Hospital Moves Long-Term Idle Listing Proceeds into Low-Risk Wealth Products
Xikang Cloud Hospital Holdings Inc. has disclosed that actual deployment of its listing proceeds lagged earlier expectations, leaving idle funds of about HK$496.5 million at end-2024 and HK$358.4 million at end-2025, well above its original projectio...
Xikang Cloud Hospital Sets August Board Meeting to Review Interim Results
Xikang Cloud Hospital Holdings Inc. has scheduled a board meeting for 26 August 2026 to review and approve the interim financial results for the six months ended 30 June 2026. The board will also consider the possible recommendation of an interim div...
Xikang Cloud Hospital Grants 32.8 Million Share Options Under Post-IPO Scheme
Xikang Cloud Hospital Holdings Inc. has granted 32,785,000 share options to 195 eligible participants under its Post-IPO Share Option Scheme, with each option entitling the holder to subscribe for one ordinary share at an exercise price of HK$0.868....
Xikang Cloud Hospital to Deploy Idle IPO Funds into Low-Risk Cash Management
Xikang Cloud Hospital Holdings Inc. has resolved to continue deploying part of its idle proceeds from its HK$554.5 million global offering into low-risk, highly liquid wealth management products for cash management purposes. The board has approved a...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 06, 2026